| Previous Close | 0.002 |
| Open | 0.001 |
| Volume | 40,000 |
| Avg. Volume (3M) | 4,525,725 |
| Market Cap | 21,013,400 |
| Price / Sales | 2.55 |
| Price / Book | 86.47 |
| 52 Weeks Range | |
| Earnings Date | 13 Feb 2025 |
| Profit Margin | -29.14% |
| Operating Margin (TTM) | -32.39% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | 14.30% |
| Total Debt/Equity (MRQ) | 49.38% |
| Current Ratio (MRQ) | 1.06 |
| Operating Cash Flow (TTM) | -1.96 M |
| Levered Free Cash Flow (TTM) | -1.22 M |
| Return on Assets (TTM) | -65.55% |
| Return on Equity (TTM) | -284.12% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Application (SG) | Mixed | Mixed |
| Software - Application (Global) | Mixed | Mixed | |
| Stock | DISA | - | - |
AIStockmoo Score
0.4
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| DISA | 21 M | - | - | 86.47 |
| 17LIVE GROUP | 146 M | - | - | 1.30 |
| IFAST | 2 B | 0.76% | 34.14 | 7.20 |
|
DISA Ltd is an investment holding company. The company's operating segments are Technology and Investment holding. It generates maximum revenue from the Technology segment. Geographically, it derives a majority of revenue from Hong Kong and also has a presence in Singapore; United States, and the People's Republic of China. |
|
| Sector | Technology |
| Industry | Software - Application |
| Investment Style | Small Value |
| % Held by Insiders | 34.56% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chng (Weng Wah) | 12 Dec 2024 | 1,522,020,850 (14.49%) |
| Tan (Hui Song) | 16 Sep 2024 | 250,000,146 (2.38%) |
| Chua (Teck Heng) | 16 Sep 2024 | 158,120,000 (1.50%) |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Mar 2025 | Announcement | General Announcement::CLINICAL DEPLOYMENT OF AVAT DEVICES AT A HOSPITAL OPHTHALMOLOGY CLINIC IN HONG KONG |
| 26 Feb 2025 | Announcement | REPL::General Announcement::DISA BUSINESS UPDATES |
| 24 Feb 2025 | Announcement | General Announcement::DISA PITCH DECK |
| 13 Feb 2025 | Announcement | Financial Statements and Related Announcement::Half Yearly Results |
| 20 Jan 2025 | Announcement | General Announcement::DLL ANNOUNCES THE CLINICAL DEPLOYMENT OF AVAT |
| 13 Jan 2025 | Announcement | General Announcement::SIGNING OF NON-BINDING TERM SHEET |
| 09 Jan 2025 | Announcement | Employee Stock Option/ Share Scheme::GRANT OF OPTIONS PURSUANT TO THE DISA EMPLOYEE SHARE OPTION SCHEME 2021 |
| 08 Jan 2025 | Announcement | General Announcement::DLL SIGNED LICENSING AGREEMENT WITH NUH AND NUS |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |